Skip to main content
AMCP Nexus 2023 Main banner

Making the Way for Innovation

(W5) Implementation of a Novel Oncology Home Infusion Model

Wednesday, October 18, 2023
2:45 PM – 4:00 PM East Coast USA Time
Location: Royal
CPE
ACPE UAN:0233-0000-23-062-L01-P | Contact Hours: 1.25 | Activity Type: Knowledge-based
In response to the COVID-19 pandemic, Horizon Blue Cross Blue Shield of New Jersey partnered with Rutgers’ Cancer Institute of New Jersey/RWJBarnabas Health on a collaborative pilot program to promote home infusion of oncology therapeutics as an alternative to the conventional receipt of therapy at an oncology infusion center. The goal of the project was to improve the patient experience while maintaining quality patient care – all at a lower total cost of care.

Join this session to hear faculty cover learnings from the program including operational components around drug selection, inclusion/exclusion member criteria, navigation of member benefits, and outcomes tracking. Faculty will also highlight results of the pilot including strong patient satisfaction scores and total cost of care savings.

Learning Objectives::

At the completion of this activity, participants should be able to:
  1. Describe the impact of the COVID-19 pandemic on oncology infusions.
  2. Identify the benefits of existing site of care models compared to historic challenges of including oncology drugs for payers and hospital systems.
  3. Review operational aspects of a successful oncology home infusion program on drug and patient selection, 340B impacts, and tracking/monitoring.
  4. Discuss the benefits of an oncology home infusion program as an innovative care delivery model including impact on patient satisfaction, provider experience, and total cost of care.